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Summary
 
During T cell development, thymocytes which are tolerant to self-peptides but reactive to for-
eign peptides are selected. The current model for thymocyte selection proposes that self-pep-
tide–major histocompatibility complex (MHC) complexes that bind the T cell receptor with
low affinity will promote positive selection while those with high affinity will result in negative
selection. Upon thymocyte maturation, such low affinity self-peptide–MHC ligands no longer
provoke a response, but foreign peptides can incidentally be high affinity ligands and can there-
fore stimulate T cells. For this model to work, thymocytes must be more sensitive to ligand
than mature T cells. Contrary to this expectation, several groups have shown that thymocytes
are less responsive than mature T cells to anti-T cell receptor for antigen (TCR)/CD3 mAb
stimulation. Additionally, the lower TCR levels on thymocytes, compared with T cells, would
potentially correlate with decreased thymocyte sensitivity. Here we compared preselection thy-
mocytes and mature T cells for early activation events in response to peptide–MHC ligands.
Remarkably, the preselection thymocytes were more responsive than mature T cells when
stimulated with low affinity peptide variants, while both populations responded equally well to
the antigenic peptide. This directly demonstrates the increased sensitivity of thymocytes com-
pared with T cells for TCR engagement by peptide–MHC complexes.
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T
 
hymic selection is essential for generating a successful
T cell repertoire which is able to respond to foreign
peptides while remaining tolerant to self-peptides. Positive
selection ensures differentiation and survival of thymocytes
with a functional TCR while negative selection removes
those thymocytes with dangerously high reactivity to self
(1). Thymocyte positive and negative selection and mature
T cell activation all depend on the same TCR interacting
with a peptide–MHC ligand. Therefore, understanding the
TCR signal in different cellular contexts is essential for un-
derstanding T cell immunity. Experiments investigating the
peptide requirement for selection of MHC class I restricted
TCR have found that very low concentrations of the anti-
genic peptide (2, 3) or variants of the antigenic peptide (4)
can mediate positive selection in fetal thymus organ cul-
ture. Subsequently, the affinity of these variant peptide–
MHC complexes for the OT-I TCR was determined and
found to be lower than for the antigenic peptide–MHC
complex (5). These data are consistent with the proposed
avidity model of selection where low avidity complexes
promote survival and differentiation whereas high avidity
ligands drive death (6, 7).
A requirement of this model, where self-peptides posi-
tively select thymocytes which develop into T cells that are
nonreactive to self, is that the thymocytes must be more
sensitive to ligand than mature T cells. Many of the variant
peptides (4, 8, 9) and naturally occurring self-peptides (10,
11) which are able to positively select TCR transgenic thy-
mocytes are non or weakly stimulatory for mature T cells.
In addition, thymocyte deletion has been shown to be
more sensitive than peripheral T cell proliferation in re-
sponse to titration of antigenic peptide in vitro (12), super-
antigen in vitro (13), or viral variants in vivo (14). The
drawback to these comparisons is that two different systems
are being analyzed, an inevitable consequence of studying
late activation events given that double positive (DP)
 
1
 
 thy-
mocytes die in response to agonist stimulation while T cells
proliferate. By measuring early events associated with TCR
stimulation that are common to both cell populations, it is
 
1
 
Abbreviations used in this paper:
 
 DP, double positive; MESF, molecules of
equivalent soluble fluorescence; PEC, peritoneal exudate cells; SP, single
positive; Tg, transgenic.
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possible to directly compare thymocytes and T cells in the
same assay. Surprisingly, experiments comparing calcium
flux in response to TCR cross-linking by mAb found that
DP thymocytes are less responsive than mature thymocytes
or T cells (15–17). This lower sensitivity of DP thymocytes
is inconsistent with the proposed model and the biological
behavior of DP thymocytes (as described above).
In this paper, we use stimulation with peptide–MHC
ligands to further analyze the differences between thymo-
cyte and T cell early responses. Three common parameters
were examined: CD69 upregulation, TCR downregula-
tion, and calcium mobilization. The central role of intra-
cellular calcium in T cell activation has been investigated
extensively (18). The CD69 molecule is a type II C-type
lectin receptor expressed on a subset of DP and single posi-
tive (SP) thymocytes and a small proportion of mature T
cells (19). CD69 expression is associated with activation
and the molecule can be detected on T cells within 2 h af-
ter stimulation through the TCR (20). Similarly, TCR
downregulation has been shown to correlate with TCR
occupancy and to be proportional to the T cell’s biological
response (21). However, unlike CD69 modulation and cal-
cium flux, TCR downregulation appears to be indepen-
dent of TCR signal transduction (22, 23).
In this study, we found that T cells were more sensitive
than thymocytes to anti-CD3 mAb stimulation, as previ-
ously described. However, in response to low affinity pep-
tide–MHC complexes, thymocytes were more sensitive
than mature T cells despite lower TCR levels.
 
Materials and Methods
 
Mice and Cells.
 
OT-I is a C57BL/6 transgenic strain express-
ing a TCR specific for the OVA peptide (OVAp, SIINFEKL) in
the context of MHC class I molecule K
 
b
 
 (4). TAP
 
o
 
 is a 129 
 
3
 
C57BL/6 strain with a targeted mutation of the TAP-1 gene on
both chromosomes (gift of Anton Berns, Netherlands Cancer In-
stitute, Amsterdam, The Netherlands). RAG
 
o
 
 is a C57BL/6 strain
with a targeted mutation of the RAG-1 gene on both chromo-
somes, obtained from The Jackson Laboratory (Bar Harbor, ME).
TAP
 
o
 
 and RAG
 
o
 
 mice were crossed with OT-I to give OT-I
TAP
 
o
 
 and OT-I RAG
 
o
 
 mice, respectively. In some experiments
OT-I lymph node cells were enriched for CD8
 
1
 
 cells using a
negative selection mouse CD8 Cellect
 
TM
 
 column (Cytovax Bio-
technologies Inc., Alberta, Canada).
 
Peptides and Antibodies.
 
OVAp variant peptides were used at
1 and 10 
 
m
 
M. V-OVA is RGYNYEKL; E1 is EIINFEKL; G4 is
SIIGFEKL; N6 is SIINFNKL. The properties of these peptides in
the OT-I system have been detailed elsewhere (4, 24, 25).
The anti-CD3 mAb (clone 500A2) was used for TCR stimula-
tion, plate bound for the in vitro assays, and cross-linked with
goat anti–mouse Ig (Sigma Chemical Co., St. Louis, MO) for cal-
cium flux experiments. For flow cytometry the following anti-
bodies from PharMingen (San Diego, CA) were used: CD4
(RM4-5), CD8 (53-6.7), CD69 (H1.2F3), V
 
a
 
2 TCR (B20.1),
and V
 
b
 
TCR (H57-597).
 
In Vitro Assay for CD69 Upregulation and TCR Downregula-
tion.
 
5 
 
3
 
 10
 
5
 
 thymocytes, spleen, or lymph node cells from
OT-I TAP
 
o
 
 or OT-I mice and 10
 
5
 
 APCs were prepared in
RPMI/10% FCS, and peptide was added where required. The
cells were pelleted together in a round bottom 96-well plate and
incubated for 3 h at 37
 
8
 
C, 5% CO
 
2
 
. The APCs were either peri-
toneal exudate cells (PEC) from TAP
 
o
 
 mice or the 5AK
 
b
 
 cell line,
a mouse fibroblast cell transfected with H-2K
 
b
 
 (26, 27). The
TAP
 
o
 
 PEC (predominantly macrophages) were generated by in-
jecting TAP
 
o
 
 mice intraperitoneally with 1 ml of thioglycollate 5 d
before harvesting cells by peritoneal wash.
For TCR cross-linking by antibody, diluted anti-CD3 mAb in
0.1 M NaHCO
 
3
 
, pH 8.1, was incubated in flat bottom 96-well
plates, 4
 
8
 
C overnight. The wells were subsequently washed twice
with PBS/0.05% Tween 20 and twice with PBS before adding
the cells, centrifuging plates, and incubating for 3 h at 37
 
8
 
C, 5%
CO
 
2
 
. In experiments where TAP
 
o
 
 PEC were used to present the
anti-CD3 mAb, cells and mAb were incubated together for 1 h
on ice, washed, and aliquoted into 96-well round bottom plates.
After the 3-h incubation the cells were simultaneously labeled
for flow cytometry with CD4, CD8, CD69, and the transgenic
(Tg) V
 
a
 
2 TCR antibodies. Forward and side scatter gating was
used to eliminate dead cells. Populations of interest were identi-
fied on the basis of CD4 and CD8 staining. CD69 and TCR
staining of these gated populations were subsequently analyzed.
The data were normalized to account for the lower level of
TCRs on unstimulated DP thymocytes and, conversely, the
greater CD69 expression attained by T cells after maximal stimu-
lation relative to thymocytes. To normalize the TCR data for
each cell subset, TCR levels in the presence of APC but no pep-
tide were set at 100%. Therefore the percentage of TCR down-
regulation was calculated by dividing the mean channel fluores-
cence with peptide by the mean channel fluorescence without
peptide and multiplying the result by 100. To normalize the
CD69 data, the levels of CD69 in the presence of saturating
OVAp (generally 5 nM) were set at 100%. Therefore the per-
centage of CD69 upregulation was calculated by dividing the
mean channel fluorescence for that peptide dilution by the mean
channel fluorescence for saturating OVAp and multiplying the
result by 100.
 
Calcium Flux.
 
2 
 
3
 
 10
 
6
 
 freshly isolated lymphocytes in 1 ml of
media (RPMI/3% FCS) were incubated at 37
 
8
 
C for 1 h with 5 
 
m
 
g
of Indo-1-AM (1 mg/ml in DMSO; Molecular Probes, Inc., Eu-
gene, OR). Immediately before stimulation the cells were washed
twice with warm media and resuspended at 10
 
6
 
 cells/ml. Expo-
sure to light was minimized during this procedure to avoid
bleaching effects. The APCs were incubated with 10 
 
m
 
M peptide
at 37
 
8
 
C in RPMI/10% FCS for 1 h, washed, and resuspended at
10
 
6
 
 cells/ml.
Changes in intracellular calcium were measured using a FACS-
Vantage
 
TM
 
 (Becton Dickinson, San Jose, CA) equipped with a
multiple wavelength 100-mW water-cooled argon laser and 395
 
l
 
and 530
 
l
 
 filters to maximize the R
 
max
 
/R
 
min
 
 ratio of Indo-1-AM
(28). Calcium-bound Indo was measured by the FL4 channel and
unbound Indo was measured in the FL5 channel. An attached
water bath maintained the sample at 37
 
8
 
C throughout the assay
period.
For peptide–MHC ligand stimulation, 5 
 
3
 
 10
 
6
 
 lymphocytes
were added to an equal number of APCs, gently agitated, and the
sample applied to the FACSVantage
 
TM
 
 for 1 min to determine
the basal response. The sample was then centrifuged for 6 s at
16,000 
 
g
 
 to maximize cell–cell contacts, and reapplied to the ma-
chine. This procedure took 
 
,
 
1 min and appears as a break in the
analysis trace (see Fig. 3 
 
A
 
). The sample was then read for a fur-
ther 6–8 min. For mAb stimulation, the primary antibody (20
 
m
 
g/ml) was applied after 1 min, the sample measured for 1 min,
and then the secondary antibody was applied; there was no cen- 
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trifugation of the sample. Data were analyzed using CellQuest
 
TM
 
software (Becton Dickinson).
 
TCR Quantitation.
 
TCR quantitation was undertaken by
comparing anti-V
 
a
 
2 TCR-FITC labeling with calibrated micro-
beads of known fluorescence intensity (Quantum
 
TM
 
 24; Flow
Cytometry Standards Corp. [FCSC], San Juan, Puerto Rico).
Mean fluorescence intensity data from the flow cytometry were
used to generate a value of molecules of equivalent soluble fluo-
rochrome (MESF) using the QuickCal
 
Ò
 
 software (FCSC). The
number of receptors was then calculated by dividing the MESF
value by the relative fluorescence/protein ratio for the mAb. The
relative fluorescence/protein ratio was determined by comparing
mAb fluorescence to a standard curve of freshly prepared FITC
solution (5 
 
3
 
 10
 
2
 
6
 
 to 5 
 
3
 
 10
 
2
 
9
 
 M) in a fluorometer. The relative
fluorescence/protein ratio was similar to the fluorescein/protein
ratio, determined by the manufacturer. Calculation of these num-
bers assumes that mAb binding is monovalent at saturating levels
of mAb.
 
Results and Discussion
 
Preselection Tg Thymocytes Have Fewer TCR Than Mature
T Cells.
 
CD4
 
1
 
CD8
 
1
 
 (DP) thymocytes are a heteroge-
neous population of pre- and postpositive selection cells
with no definitive marker to distinguish all postpositive se-
lection cells. Therefore, to study a homogenous population
of preselection DP thymocytes we took advantage of trans-
gene technology. The OT-I TCR Tg mice express a
V
 
a
 
2,V
 
b
 
5 TCR specific for the OVA peptide, SIINFEKL,
in the context of the MHC class I molecule, K
 
b
 
 (4). In
TAP
 
o
 
 mice, which have minimal MHC class I on the cell
surface, the selection of CD4
 
2
 
CD8
 
1
 
 (SP) T cells is severely
impaired (29). Therefore, in a TAP
 
o
 
 mouse with the OT-I
TCR, almost all the DP thymocytes are preselection and
few mature CD8 SP thymocytes develop (10). Hence,
OT-I TAP
 
o
 
 thymii provide a source of preselection DP
thymocytes which can be compared with OT-I TAP
 
wt
 
CD8 SP thymocytes and peripheral T cells.
In normal (non-TCR Tg) mice, mature T cells express
 
z
 
10-fold more TCRs on the cell surface than immature
thymocytes (30). This is also true in TCR Tg mice al-
though the difference is not as large (Fig. 1 
 
A
 
). In part this
may be due to the greater proportion of cells undergoing
positive selection in the Tg mice, and hence upregulating
their TCRs. In contrast, for normal mice the majority of
DP thymocytes are preselection. Therefore we compared
preselection TCR-Tg DP thymocytes (OT-I TAP
 
o
 
) with
DP thymocytes from a selecting environment (OT-I). The
level of TCRs on preselection OT-I DP cells was signifi-
cantly lower than for selected OT-I DP cells (Fig. 1 
 
A
 
).
However, the level on preselection OT-I DP thymocytes
was still higher than for non-TCR Tg DP thymocytes (Fig.
1 
 
B
 
). These data confirm that DP thymocytes maintain low
TCR surface levels until after positive selection, despite the
fact that in 
 
ab
 
TCR Tg mice the TCR is expressed at high
levels on double negative precursor cells (31, 32). Most
probably, the low TCR level on OT-I DP cells is due to
degradation of the TCR
 
a
 
 chains in the endoplasmic retic-
ulum, as seen in wild-type mice (33).
 
DP Thymocytes Are More Sensitive to Low Affinity Ligands.
 
In view of the fact that thymocytes have fewer TCRs, a
comparison of their sensitivity to TCR stimulation was un-
dertaken. To directly compare the relative sensitivity of DP
thymocytes to SP thymocytes and T cells it is necessary to
have an assay relevant to both immature and mature cell
types. Therefore CD69 upregulation, an early activation
event common to both thymocytes and T cells, was mea-
sured after in vitro stimulation with peptide–MHC com-
plexes on APCs. TCR-dependent CD69 upregulation in
mature T cells requires sustained activation of Ras (34), cal-
cium flux, and PKC activation (20, 35).
In previous experiments, when DP thymocytes or T
cells were activated through TCR cross-linking, the T cells
showed a greater magnitude of calcium flux than DP thy-
mocytes (15–17). Thus, we tested whether CD69 upregu-
lation would follow a similar pattern. In this experiment
plate-bound anti-CD3 mAb was used to stimulate different
T cell subsets. Fig. 2 
 
A
 
 shows that CD69 upregulation was
more readily activated in T cells or mature thymocytes
compared with preselection DP thymocytes. CD8 SP thy-
mocytes and T cells attained maximal CD69 expression
when exposed to 2 
 
m
 
g/ml anti-CD3 antibody, whereas the
preselection DP thymocytes were submaximal even at 60
 
m
 
g/ml (data not shown). Given the differences in the affin-
ity and kinetics of binding for antibody versus peptide–
MHC ligands (36), it was of interest to compare anti-CD3
mAb stimulation to the more physiologically relevant pep-
tide–MHC ligands.
Three populations, preselection DP thymocytes, CD8
SP thymocytes, and CD8 SP T cells, were incubated for 3 h
with titrated OVAp in the presence of TAP
 
o
 
 PEC as the
APC. Unlike the anti-CD3 mAb stimulation, each popula-
tion responded similarly to the antigenic peptide–MHC
complex (Fig. 2 
 
B
 
). Upregulation of CD69 was first detect-
able at 5–50 pM and was maximal at 50 nM. As the inten-
sity of CD69 expression and number of cells which re-
spond is different between thymocytes and T cells, the data
are normalized such that 100% corresponds to CD69 levels
on each population stimulated with the highest concentra-
Figure 1. Surface TCR levels
are lower on DP thymocytes
than T cells from OT-I mice.
(A) Flow cytometry histograms
of Va2 TCR expression on
splenic T cells (solid line) or DP
thymocytes (dashed line) from
OT-I mice and preselection DP
thymocytes (dotted line) from
OT-I TAPo mice. (B) Flow cyto-
metry histograms of pan Vb
TCR expression on splenic T
cells (solid line) or DP thymocytes
(dashed line) from non-TCR Tg
mice, splenic T cells (dash-dot
line) from OT-I mice, and prese-
lection DP thymocytes (dotted
line) from OT-I TAPo mice. 
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tion of OVAp. The same result was obtained whether cells
were analyzed for the percentage of CD69
 
1
 
 cells or the
change in mean fluorescence intensity (data not shown).
Possible explanations for the lack of thymocyte response
to anti-CD3 mAb may be the lower levels of TCRs on the
cell surface. In contrast to the relatively low affinity binding
of peptide–MHC, antibody binding has a high affinity and
a slow off-rate (36). Therefore, the difference in TCR
number may be more significant if the TCR cannot be se-
rially triggered (21). Alternatively, the APCs may be pro-
viding adhesion molecules or costimulators which prefer-
entially lower the signaling threshold for thymocytes but
not T cells. To address this, FcR
 
1
 
 TAP
 
o
 
 PEC were used
to present and cross-link the anti-CD3 mAb, rather than
using plate-bound mAb. Even under these conditions,
CD8 SP T cells were still more responsive than the prese-
lection DP thymocytes (Fig. 2 
 
C
 
). Therefore, the inability
of thymocytes to respond optimally to anti-CD3 mAb may
reflect the lower TCR numbers on the cell surface and a
quantitatively different signal and/or differences in ligand
binding resulting in a qualitatively different signal relative
to peptide–MHC ligand stimulation.
The most interesting result was obtained when OVA
variant peptides were used for stimulating the TCRs (Fig.
2 
 
D
 
). The selected variants were chosen to encompass a
spectrum of agonist strength for the OT-I TCR, as charac-
terized previously (4, 24, 25). A correlation between ago-
nist strength and TCR affinity for peptide–MHC ligands
has been observed (5). As seen with OVAp, the strong ago-
nist peptide N6 induced considerable upregulation of
CD69 in all the cell subsets (the greater magnitude of the
CD8 SP T cell response was not consistently observed).
However, for peptide G4, CD69 upregulation was observed
for the preselection DP thymocytes but not the CD8 SP
thymocytes or mature T cells. In some experiments a re-
sponse to peptide E1 was detected for the DP thymocytes
only (data not shown). V-OVA, although able to positively
select OT-I T cells in fetal thymic organ culture (4), did
not stimulate detectable CD69 upregulation at this time
point in the assay. Identical results were obtained using a
mouse fibroblast cell line transfected with K
 
b
 
 (26, 27) as the
APC (data not shown). This enhanced sensitivity of thy-
mocytes to variant peptide–MHC ligands was also observed
at an 18-h time point (data not shown).
The greater response of DP thymocytes to OVAp–
MHC ligand compared with TCR cross-linking by mAb
may be explained, at least in part, by the participation of
CD4 and CD8 coreceptors. Previous work has found that
costimulation with TCR/CD4 over TCR cross-linking
alone improved the calcium flux in thymocytes (37) and
the activation of Zap-70 in T cells (38). Similarly, we ob-
served enhanced CD69 upregulation in response to anti-
CD3 and anti-CD8 mAb cross-linking on DP thymocytes
relative to anti-CD3 alone (data not shown). However,
when comparing the response with OVAp or variants, the
involvement of coreceptors is equivalent for the thy-
mocytes and T cells. The fact that the thymocytes and T
cells were indistinguishable in their response to strong stim-
uli such as OVAp, but different for weak stimuli such as G4
is consistent with previous data in the OT-I system and
others, which suggests that low concentrations of antigenic
peptide cannot substitute for low affinity ligands in the pos-
itive selection of functionally competent mature cells (39,
40). Whether this is because low affinity ligands give a
qualitatively (41, 42) or quantitatively different signal in
thymocytes remains to be determined.
 
Preselection DP Thymocytes Flux Calcium in Response to
Low Affinity Ligands.
 
In addition to CD69 upregulation,
an increase in intracellular calcium levels is an early activa-
tion event occurring in both thymocytes and T cells.
Therefore we were interested in whether the same sensitiv-
ity of preselection DP thymocytes to stimulation by pep-
tide–MHC ligands could be seen by measuring changes in
intracellular calcium. Thymocytes and T cells were loaded
with the calcium binding dye, Indo-1-AM, and stimulated
with anti-CD3 mAb or APCs loaded with no peptide–G4
or OVAp. Upon binding calcium, the fluorescence of
Indo-1 changes and this can be measured by flow cytome-
try, where FL4 detects calcium bound Indo, FL5 detects
unbound Indo-1, and the ratio of FL4/FL5 is determined.
The magnitude of the change in FL4/FL5 correlates with
the increase in intracellular calcium (28). Fig. 3 A shows
the change in the FL4/FL5 ratio over time for preselection
DP thymocytes exposed to different stimuli. To quantitate
this data, FL4/FL5 histograms were divided into adjacent
nonoverlapping regions corresponding to low, intermedi-
ate, high, and very high FL4/FL5 ratios. Fig. 3 B shows
representative histograms of this analysis for DP thymocytes
Figure 2. CD69 upregulation on preselection DP thymocytes and T
cells stimulated with various ligands. Immature and mature T cells were
stimulated, for 3 h at 378C, with dilutions of plate-bound anti-CD3 mAb
(A), OVAp 1 APC (B), anti-CD3 1 APC (C), or OVA variant peptides 1
APC (D). For preselection (OT-I TAPo) DP thymocytes (squares), OT-I
CD8 SP thymocytes (circles), and OT-I CD8 SP splenocytes (triangles),
the percentage of CD69-expressing cells on CD4/CD8-defined subpop-
ulations was determined by flow cytometry. The data have been normal-
ized such that the percentage of CD691 cells in the presence of 5 mM
OVAp 5 100% for each cell subset. The graphs shown are representative
of data from six to eight independent experiments.1871 Davey et al.
mixed with no peptide and OVAp-loaded APCs. A sum-
mary of this analysis for preselection DP thymocytes and
CD8 SP T cells is graphed in Fig. 3 C. To avoid the poten-
tial complication of stimulating the cells through antibody
labeling, preselection DP thymocytes were isolated from
TAPo OT-I thymii (.85% CD41CD81), and used with-
out further purification. For the CD8 SP T cells, unpuri-
fied lymph node and spleen cells from OT-I RAGo animals
(80% CD42CD81) or OT-I negative selection column
chromatography purified OT-I lymph node cells (.90%
CD42CD81) were used. Similar results were obtained
with each cell population.
Both the trace (Fig. 3 A) and graph (Fig. 3 C) show that
a significant proportion of both thymocytes and mature T
cells increase intracellular calcium levels in response to anti-
CD3 mAb stimulation. For the preselection DP thy-
mocytes, most of the responding cells have a low FL4/FL5
ratio in comparison with the CD8 SP T cells, where the
responding cells have an intermediate to very high re-
sponse. Hence, these data using TCR Tg cells are consis-
tent with previous data in non-TCR Tg systems showing
that mature T cells are more responsive to anti-TCR mAb
cross-linking than DP thymocytes (15–17). For stimulation
with OVAp, an increase in intracellular calcium was seen in
both the preselection DP thymocytes and the mature T
cells, with a broad spectrum of individual cell responses
from low to very high FL4/FL5 ratios. For the preselection
DP thymocytes stimulated with the OVA variant, G4, a
distinct calcium flux was detected, albeit fewer cells re-
sponded and with a smaller magnitude of response relative
to activation by OVAp. In contrast, no response to G4 was
detected in the CD8 SP T cells. Therefore, consistent with
the CD69 analysis, preselection DP thymocytes are exquis-
itely sensitive to stimulation by low affinity ligands but are
less sensitive to mAb cross-linking of the TCR complex
relative to mature SP T cells. Further examination of the
calcium response at the individual cell level to assess latency
and oscillations in response to peptide–MHC ligands may
reveal further differences with implications for cell function
(17).
TCR Engagement Is Equivalent Between Thymocytes and T
Cells. The enhanced responsiveness of thymocytes to low
affinity peptide–MHC ligands could be explained by more
efficient TCR signal transduction in thymocytes and/or a
preferential increase in nonspecific adhesion between thy-
mocytes and APCs relative to T cells. To distinguish be-
tween these two possibilities we measured the number of
TCRs downregulated in response to stimulation. TCR
downregulation has been shown to correlate with TCR
occupancy and be proportional to the T cell’s biological re-
sponse (21, 43). Additionally, in contrast to CD69 upregu-
lation, TCR downregulation is independent of TCR signal
transduction, as it is not blocked by inhibitors of protein
tyrosine kinases, protein C kinases, lipid kinases, protein
synthesis, or actin polymerization (22, 23) (Schober, S.L.,
and S.C. Jameson, unpublished data). Therefore, if nonspe-
Figure 3. Changes in intracellular cal-
cium in DP thymocytes and T cells stimu-
lated with various ligands. (A) Dot plots of
FL4/FL5 versus time for preselection (OT-I
TAPo) DP thymocytes stimulated with APC
alone, anti-CD3 mAb 1 goat anti–mouse
Ig, OVAp 1 APC, and G4 1 APC. The
break in the trace corresponds to the time
where the T cells and APCs were centri-
fuged together before being resuspended
gently to pass through the flow cytometer.
The two breaks for mAb cross-linking cor-
respond to the sequential addition of anti-
CD3 mAb and the goat anti–mouse Ig. (B)
Representative histograms for FL4/FL5 of
preselection DP thymocytes with APC
alone or 10 mM OVAp, showing nonover-
lapping markers set for low, intermediate,
high, and very high expressing cells corre-
sponding to increased intracellular calcium
levels. Histogram data are based on the gate
shown in A. (C) Graphs of the percentage
of cells in each FL4/FL5 gate for preselec-
tion DP thymocytes and OT-I CD8 SP
splenocytes stimulated with anti-CD3 mAb,
OVAp, and G4 peptide. Markers were set as
in B. Background levels determined by the
APCs alone control have been subtracted
from the values graphed. The APCs used in
this experiment were of the 5AKb cell line.
Similar results were seen using TAPo PEC
as the APCs. The data shown are represen-
tative of four independent experiments.1872 Enhanced Thymocyte Sensitivity to Peptide–MHC
cific adhesion interactions are increasing the area of contact
between thymocytes and APCs then more TCRs will be
downregulated in thymocytes compared with T cells upon
exposure to the same ligand concentration.
The number of TCRs downregulated in response to
OVAp presentation was quantitated for preselection DP
thymocytes and CD8 SP splenocytes which, as shown
above, respond equally in terms of CD69 upregulation
(Fig. 2 B). The quantitative analysis was performed using
flow cytometry and comparison to beads with known con-
centrations of fluorochrome. At high concentrations of
peptide, the CD8 SP T cells will downregulate a greater
number of TCRs as they have more TCRs than DP thy-
mocytes. However, at lower OVAp concentrations, the
initial numbers of TCRs downregulated can be deter-
mined. Table 1 shows that preselection DP thymocytes and
T cells initiate TCR downregulation at a similar OVAp
concentration, 1–10 pM. However, the thymocytes down-
regulate fewer TCRs than mature T cells at any given
OVAp concentration. Hence, it is unlikely that preselec-
tion DP thymocytes are more sensitive to low affinity vari-
ant peptide ligands due to increased nonspecific adhesion to
the APC. Indeed, the same biological response observed
for fewer TCRs downregulated is more consistent with
enhanced TCR signal transduction in the preselection DP
thymocytes.
Conclusion. For thymocytes to be positively selected by
low avidity ligands, the DP thymocytes must be more sen-
sitive than mature T cells. To the contrary, previous data
directly comparing thymocytes and T cells found thy-
mocytes were less sensitive when stimulated with anti-
TCR mAb. In the experiments described here, early acti-
vation events in immature and mature T cells stimulated
with peptide–MHC complexes were investigated. We
have demonstrated the unique sensitivity of a defined pre-
selection thymocyte population to low affinity ligands.
The increase in CD69 and intracellular calcium levels
seen in the preselection thymocytes in response to low af-
finity peptide–MHC ligands is consistent with observations
of in vivo positive selection. In the HY TCR Tg mice a
subset of CD691 DP cells was seen in thymocytes from fe-
male mice on a selecting MHC background (44). Likewise,
the development of late stage DP thymocytes in female
HY-TCR Tg mice was blocked by inhibitors of cal-
cineurin, a component of the calcium signaling pathway
(45, 46).
As seen in normal mice, TCR Tg thymocytes maintain
low levels of TCRs at the DP stage. A cell with fewer re-
ceptors would be expected to be less sensitive than a cell
with more receptors. On the other hand, if the thymocyte
is more sensitive due to more efficient signal amplification
or altered signaling pathways then low TCR levels may be
a protective mechanism to prevent inappropriate negative
selection.
A caveat concerning the conclusions of these experiments
is that the two APCs used may express a costimulator that
preferentially lowers the signaling threshold in thymocytes
but not in T cells. This would make the thymocytes selec-
tively more sensitive rather than inherently so. However, if
this were the case, a difference in the response to OVAp
might also be expected, whereas we found the response be-
tween thymocytes and T cells to be the same.
Therefore, the challenge is to identify the differences in
the signaling pathways downstream of the TCRs which
mediate this enhanced sensitivity of preselection DP thy-
mocytes to low affinity ligands. In DP thymocytes a signifi-
cant proportion of the z chains are tyrosine phosphorylated
although the effect of this on signal transduction remains to
be clarified (47, 48). In addition, a number of molecules
with different expression levels between DP thymocytes
and T cells such as the protein tyrosine kinases Fyn (49) and
Syk (50) and the protein phosphatase, Shp-1 (Davey,
G.M., and K.A. Hogquist, unpublished data) are interesting
candidates for further investigation.
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this manuscript.
Table 1. The Number of TCR Downregulated on Thymocytes 
and T Cells in Response to OVAp 1 APC
OVAp
TCR number internalized‡
Preselection
DP thymocytes
CD8 SP
splenocytes
pM*
000
0.5 210 6 16 22 6 65
1.4 261 6 52 182 6 83
4.1 76 6 42 252 6 74
12.3 158 6 31 601 6 77
37 351 6 10 1,070 6 118
111 581 6 58 1,666 6 146
333 860 6 59 2,279 6 67
1,000 1,131 6 63 3,340 6 301
3,000 1,311 6 42 4,464 6 408
*Preselection (OT-I TAPo) DP thymocytes or OT-I CD8 SP spleno-
cytes were incubated for 3 h with dilutions of OVAp and APC. The
APC in these experiments was the 5AKb cell line.
‡TCR numbers were quantitated by flow cytometry with reference to
beads of known fluorochrome levels. The number of TCR downregu-
lated was calculated by (number of TCR for APC 1 no peptide) 2
(number of TCR at peptide dilution). Values shown are the mean 6
SD for triplicate samples.1873 Davey et al.
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